We screened for adhesion-associated coupling activity using lacrimal acinar cells and have identified "BM180," a novel basement membrane protein enriched in guanidine HCl extracts of lacrimal and parotid exocrine secretory glands. BM180 resides primarily in a previously unexamined lower molecular-mass basement membrane peak (peak 2) that contains cell adhesion activity inhibitable with the anti-BM180 monoclonal antibody 3E12. Removal of peak 2 by gel filtration or preincubation of basement membrane with 3E12 decreased regulated peroxidase secretion by onehalf without affecting constitutive secretion or the amount of cellular peroxidase available for release. Adding back peak 2 restored regulated secretion in a dose-dependent and 3E12-inhibitable manner and suggested a synergistic relationship between BM180 and laminin 1. BM180 has a mobility of 180 and 60 kDa in the absence or presence of dithiothreitol, respectively, and shows no immunological identity by competitive enzyme-linked immunosorbent assay with laminin 1, collagen IV, entactin, fibronectin, BM-40, perlecan, or vitronectin. We propose that BM180 is an important resident of certain glandular basement membranes where it interacts with the cell surface, thereby possibly signaling the appearance of a transducing element in the stimulus-secretion coupling pathway. extracellular matrix; cell adhesion; exocrine cells DIFFERENTIATION of epithelia and several other cell types is activated in part by cellular adhesion with the newly formed basement membrane in a compositionally dependent and partially reversible manner (18). Regulated secretion, defined as the release of stored secretory products from membrane-bound granules under the external influence of secretogogue (9), is a complex example of cellular differentiation.
By use of the exocrine pancreas as a model, a series of differentiative events whose progression appears attributable to mesenchymal-epithelial interactions (13) and to products of these interactions, including the newly formed acinar basement membrane (22), have been described. Cell polarization is followed by elaboration of protein synthetic (32) and signal transduction machinery and appearance of cholecystokinin receptors on the basal cell surface (10). In late gestation, constitutive secretion becomes active, but regulated secretion of accumulating apical secretory granules is delayed until after birth, at which time a Ca2+-transducing element is acquired, thereby coupling the stimulus to the potential secretory response (10).
Identification of putative developmental regulators of stimulus-secretion coupling has received little attention. Cell lines, such as (2, 3, 19, 29) , acini (ll), or lobules (19) are initial1 y responsive to secretagogue but illustrate gradual decoupling, particularly acinar cell preparations in which both cell-cell and cell-basement membrane interactions have been disrupted during isolation. Taken together, these observations raise the possibility that cell lines, but not primary cultures, produce an inducible factor(s), which in some way is required to develop the capacity for regulated secretion, and that possibly basement membrane components may be involved.
To search for such factors, we turned to a novel basement membrane substrate (BMS), which was found to support both adhesion and secretogogue responsiveness in primary cultures of rat lacrimal acinar cells. Adhesion-associated coupling activity was pursued by testing gel filtration peaks of BMS; monoclonal antibodies (MAbs) were prepared against a lower molecularmass peak leading to the identification of a novel lacrimal and parotid gland-enriched basement membrane protein, "BM180."
METHODS

Preparation
of substrates. A 10 mM EDTA extract of EHS tumor matrix, first used in cell culture by Matter and Laurie (Ref. 27 ; hereafter referred to as BMS for basement membrane substrate), was prepared at 4°C essentially according to the method of Paulsson et al. (30) with slight modifications (27). For gel filtration (4"C), BMS was passed over a Biogel A1.5m column (2.5 X 100 cm; Refs. 27, 30), resulting in separation of the laminin 1-entactin complex from a broad peak of uncharacterized basement membrane material (hereafter referred to as peak 2 (1 ug/ml), putrescine (1 mM), epidermal growth factor (EGF, 50 rig/ml), L-ascorbic acid (25 ug/ml), insulin (6 ug/ml), transferrin (6 pg/ml), selenous acid (6 rig/ml), red uced glutathione (10 ug/ml), iV-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES, 15 mM), heatinactivated fetal calf serum (lo%), and gentamicin (50 ug/ml Detection was with a peroxidase-labeled sheep anti-rat antibody (Amersham, Arlington Heights, IL; diluted 1:lOO in PBS, 1% BSA), which had been preabsorbed on a BMS-Sepharose column to eliminate background. Bound antibody was revealed with metal-enhanced DAB (Pierce, Rockford, IL). For Western blots, BMS was separated by SDS-PAGE on 5-15% gradient gels and transferred in tris(hydroxymethyl)aminomethane-glycine-methanol to nitrocellulose. Blots were blocked with 5% milk, PBS, and 0.1% Tween and incubated with purified 3E12 MAb diluted to 3 pglml in PBS, 0.1% Tween, and 1% BSA. Blots were incubated with a secondary peroxidase-conjugated goat anti-rat F(ab')z-specific antibody (Jackson Immunoresearch) or alternatively with the BMS-preabsorbed sheep anti-rat antibody described above. Secondary antibody was diluted l:l,OOO in PBS, 0.1% Tween, and 1% normal goat serum. Detection was with chemiluminescence (Amersham).
EDTA (10 mM) followed by 6 M guanidine HCl extraction of mouse (C57BL/6, NCI) lacrimal and parotid glands, kidney, brain, pancreas, and lung was carried out according to the method of Hunter et al. (21) 
RESULTS
Adhesion to basement membrane supports regulated secretion. Basement membrane is a prominent histological feature of the lacrimal gland acinus. Using BMS, a 10 mM EDTA extract of mouse Engelbreth-Holm-Swarm basement membrane, and its constituent (Fig. 1) high (peak I)-and low (peak 2)-molecular-mass peaks, we set out to determine whether adhesion to basement membrane is functionally linked to stimulus-secretion coupling. Freshly isolated lacrimal acinar cells adhered to gelled BMS and after 24 (Fig. 2 ) or 48 h (not shown) were responsive to carbachol and VIP in a time ( Fig.  2A )-and dose (not shown)-dependent manner without loss of viability (Fig. 2B) . In contrast, cells maintained for the same period in suspension or adherent to plastic deteriorated and/or were poorly responsive (not shown).
Identification of BMS-associated activities was initiated by plating cells on BMS vs. on equal milligram amounts of gelled laminin 1 purified from peak I (Fig.  3) . BMS adherent cells were twice ( Fig. 3B ; cumulative regulated secretion over 1st 100 min) as responsive to carbachol and VIP as cells attached to laminin 1. This difference in rate (Fig. 3A) (not shown). Rupture of cell membranes by sonication and freeze thawing revealed that similar amounts of intracellular peroxidase were available for release (Fig.  3A, inset) , and the effect appeared to be entactin independent (not shown). Peak 2 contains cell adhesion activity. The implication of these studies was that a peak 2 secretionenhancing activity was required to achieve maximal levels of regulated secretion. We presumed that the putative activity may be adhesive to cells and carried out attachment studies (Fig. 4) with freshly isolated lacrimal acinar cells and HT-1080 human fibrosarcoma cells, the latter having the advantage of known avidity for basement membrane.
Coating with increasing amounts of peak 2 resulted in a dose-dependent increase in cell adhesion, which was maximal at 3-5 pg/well (Fig. 4A) , achieving a level similar to 4 pg/well ofpeak I, purified laminin 1, or BMS (Fig. 4A, inset) . Lacrimal acinar cells adhered at a lower level (Fig. 4B) , as is often observed for primary cultures. To determine the size ofpeak 2 adhesion activity, cells were incubated with blots ofpeak 2 previously separated on SDS-PAGE gels under reducing conditions (Fig. 5) . Examination in the light microscope revealed regions of few (Fig. 5a) or many (Fig. 5, b-d) dark-staining adherent cells, which, when quantitated relative to the retardation factor (I-&, Fig. 5e ), pointed to adhesive activities at 60,35, and 30 kDa,l corresponding to proteins of similar size (Fig. 5e,   inset ).
3E12 MAb inhibits peak 2 adhesion and secretionenhancing activity. Rat MAbs were prepared against peak 2 (Fig. 6 ) and screened for the ability to block cell adhesion to peak 2. Adhesion-neutralizing antibodies were subsequently screened for inhibition of peak 2 secretion-enhancing activity. Several adhesion-neutralizing antibodies were identified, including 3E12 MAb (Fig. 6A) . 3E12 MAb was also found to inhibit the secretion-enhancing activity, revealed as a reduction of regulated secretion by BMS adherent acinar cells to laminin 1 levels (Fig. 6C) . Despite the presence of 3E12 MAb, acinar cell adherence to BMS in secretion studies was near normal (not shown), an observation in keeping with an abundance of laminin 1 in BMS, and lack of effect of 3E12 on cell adhesion to laminin 1 (Fig. 6A ). Secretion study adhesion was also aided by fibronectin and/or vitronectin in the serum. 3E12 MAb slightly enhanced adhesion to collagen IV (Fig. 6A ) but had no effect on constitutive secretion (not shown) or total cellular peroxidase (Fig. 6C, inset) , and no differences were apparent in cell viability (not shown). These data were subsequently confirmed by add-back experiments using coated substrates in the presence or absence of antibody (Fig. 7) . Cocoating laminin 1 with increasing microgram amounts of peak 2 under conditions in which both substrates become immobilized on plastic gave rise to a peak 2 dose-dependent increase in regulated (Fig. 7B) but not constitutive (Fig. 7A) secretion. Cell adhesion was constant and regulated secretion remained at -26-28 mU/ug cellular DNA when peak 2 or laminin 1 were respectively coated alone at increasing amounts. Addition of 3E12 MAb to laminin 1 cocoated with an optimal amount ofpeak 2 resulted in a dose-dependent decrease in regulated secretion (Fig.  7B, inset) . No change was observed with a control antibody (Fig. 7B, inset) .
3E12 antigen BM180 enriched in lacrimal and parotid gland guanidine HC1 extracts. Characterization of 3E12 MAb by competitive ELISA revealed no immunological reactivity with the isolated matrix macromolecules laminin 1, collagen IV, entactin, perlecan core protein, BM-40, fibronectin, or vitronectin, individually tested for inhibitory activity in this assay (Fig 8) . On Western blots of BMS (Fig. 8, inset) or peak 2 (Fig. 9 Fig. 7 . Add-back of peak 2 to laminin 1 promotes a dose-dependent increase in regulated secretion which is inhibited with 3E12 MAb. A: constitutive secretion (unstim) by lacrimal acinar cells adherent for 24 h to laminin 1 alone or laminin 1 + increasing amounts ofpeak 2 remains constant. B: regulated secretion by same 24-h cultures increases in a peak 2 dose-dependent fashion. Cells were stimulated for 100 min. Amount of laminin 1 used throughout was 4 pg/well. t-Test of regulated secretion on wells treated with 4 pg laminin l/8 pg peak 2 vs. 4 pg laminin l/O.04 pgpeak 2 reveals a P = 0.03. Regulated secretion on wells coated with 10 pg ofpeak 2 or laminin 1 alone was 24 and 29 mU/pg DNA, respectively. Inset: 3E12 MAb preincubated with coated laminin 1 and peak 2 (4 pg each) inhibits regulated secretion in a dose-dependent manner. Control (ctrl) rat immunoglobulin (Ig) G has no effect. t-Test of 3E12 vs. control IgG (10 pg), P = 0.026. Representative experiment carried out in triplicate.
reduction. 3E12 MAb showed no reactivity with blots of purified laminin 1 (Fig. 8, inset) , and BMS blots incubated with secondary antibody alone followed by detection were completely blank (Fig. 9, lanes 1 and 2) . These results were in agreement with a 60-kDa adhesive activity in blots of reducedpeak 2 (Fig. 5) . Although 180-kDa proteins were not obvious in Coomassie bluestained SDS-PAGE gels of nonreduced peak 2 at usual loading levels, they became apparent with heavier loading (Fig. 1B) . BM180 distribution (Fig. 10 ) was examined in sequential 10 mM EDTA and 6 M guanidine HCl extracts of mouse adult lacrimal and parotid glands, kidney, brain, pancreas, and lung. We also tested postnatal lacrimal gland at 2 (when eyelids first open), 3, and 4 wk. EDTA-extractable BM180 was readily detected by ELISA in all above organs at levels similar to that obtained for BMS (not shown). In contrast, guanidine HCl-extractable BM180, representing a pool of BM180 firmly cross-linked into the extracellular matrix, was enriched in lacrimal and parotid glands, slightly detectable in lung, and not apparent in kidney, brain, or pancreas (Fig. 1OA ) . Frozen sections of lacrimal gland (Fig. 10, B-D) immunostained with 3E12 MAb revealed an irregular punctate periacinar staining pattern (Fig. 10, C and D) , which was absent in controls (Fig. 10B) . 
DISCUSSION
Development of the regulated secretory pathway is an elaborate example of cellular differentiation, a transition possibly activated in exocrine glands by cellular adhesion to the newly formed acinar basement membrane. A screen for adhesion-associated coupling activity has led in this study to the identification of BM180, a 180-kDa basement membrane protein enriched in guanidine HCl extracts of lacrimal and parotid glands and widespread in a EDTA-soluble form. We initially determined that BMS supported both adhesion and regulated secretion by isolated lacrimal acinar cells. Division of BMS into two parts revealed a previously uncharacterized lower molecular-mass peak (peak 2) with cell adhesion activity, the removal of which re- duced regulated secretion by one-half and when added back to laminin 1 restored regulated secretion in a dose-dependent manner. Screening of anti-peak 2 MAbs for inhibition of both cell adhesion and secretionenhancement activity subsequently identified antibody 3E12 whose antigen was designated BM180.
3E12 MAb immunostained lacrimal acinar cell basement membranes in a distinct but irregular periacinar fashion, suggesting either patchy antigen distribution or incomplete antibody accessibility. Because reagents designed to reveal blocked epitopes have to date been unsuccessful, it would appear that BM180 is sparsely distributed.
BM180 was detected in EDTA extracts of all organs examined in contrast to guanidine HClextractable BM180, which was restricted to lacrimal and parotid glands. The functional significance of two pools of BM180, one more loosely integrated in diverse tissues via divalent cations and the other firmly crosslinked in two exocrine glands, is not readily apparent, since BM180 extracted from BMS by EDTA did not require cross-linking for activity. The second pool possibly ensures stabilization of the regulated secretion phenotype in lacrimal and parotid acinar cells in the face of a potentially transient divalent cation-dependent fraction. If so, factors controlling differentiation of regulated secretion in pancreas, which lacked guanidine HCl-extractable BM180, may differ. Laminin 1 is similarly thought to reside simultaneously in EDTAsoluble and -insoluble (collagen IV-immobilized) fractions (341, with the former enhanced in developmental conditions, in which tissue remodeling is common, and the latter considered more appropriate for postdevelopmental events, in which slower turnover and structural stability is important (34). The presence of EDTAextractable BM180 in nonexocrine organs may be suggestive of BM180 as having additional functions. BM180 appears to be a minor component of basement membranes, as might be expected to be the case for most newly identified components of this partially characterized extracellular matrix. It is not a previously described basement membrane protein based on competitive ELISA and NHz-terminal sequence data (25), and BM180 shows no apparent affinity for Sepharose 4B, unlike the avian basement membrane-associated laminin 1 binding lectin (LBL). LBL, like BM180, is a trimer (190-220 kDa with 70-kDa subunits; Ref. 6). Another extracellular matrix trimer of similar mobility is cartilage matrix protein (148-kDa trimer with 52-kDa subunits; Ref. 31) . The trimeric nature of BM180 is supported by silver-stained preparations of immunopurified BM180 loaded equally, in which the 60-kDa band is denser than the nonreduced 180-kDa band (25). Lack of 3E12 MAb effect on BMS-mediated cell adhesion in secretion experiments emphasizes the considerable compensatory adhesive activity of laminin 1 (together with fibronectin in serum-containing medium) and the relatively low molar amounts of BM180 in BMS. In view of this molar deficit, the secretory modulatory potency of BM180 is notable. Aiding BM180 is an interesting modulatory synergism with laminin 1. Thus, although regulated secretion on laminin 1 or peak 2 alone remained half-maximal independent of the coating level, a dose-dependent restoration to maximal levels was possible by addition of increasing amounts ofpeak 2 to a constant amount of laminin 1, a 3E12-inhibitable effect.
How might BM180 control cellular responsiveness to secretogogue? One possibility is at the level of cell polarity. Several studies have emphasized the manner in which cellular adherence to a basal layer of laminin 1 or Matrigel promoted cell polarization (331, increased mRNA transcription, and augmented constitutive secretion (7). This, however, appears not to be the case for BM180, since 3E12 MAb and peak 2 did not affect constitutive peroxidase secretion or the peroxidase content of acinar cells. Alteration of muscarinic receptor number and/or affinity would also seem unlikely, since occupation of only a small fraction of surface receptors are required for secretory granule release (12). A third possibility is that BM180, in the presence of laminin 1, serves as an external requirement (perhaps activator) of one or several steps in the intracellular signal transduction pathway. This novel possibility would be in keeping with its restricted organ distribution in guanidine HCl-soluble fractions and with the concept of extracellular matrix molecules as agents of epithelial cell differentiation (1). 
